Atara Bio Announces Participation in Two Upcoming Immuno-Oncology Conferences
Mar 28, 2016 20:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 28, 2016 -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company developing meaningful therapies for patients with severe and life-threatening diseases that have been...
Mar 28, 2016 20:05 pm UTC| Business
MALVERN, Pa., March 28, 2016 -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a clinical stage specialty pharmaceutical company, today announced that it has entered into an agreement with the stockholders of Vixen...
Zafgen to Present Data from bestPWS Study of Beloranib in Prader-Willi Syndrome at ENDO 2016
Mar 28, 2016 20:05 pm UTC| Business
BOSTON, March 28, 2016 -- Zafgen Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity and complex metabolic disorders, today...
Gevo Announces Proposed Public Offering of Common Stock and Warrants
Mar 28, 2016 20:01 pm UTC| Business
ENGLEWOOD, Colo., March 28, 2016 -- Gevo, Inc. (NASDAQ:GEVO), a leading renewable chemicals and next-generation biofuels company, announced today that it intends to offer and sell, subject to market and other...
Supreme Court Denies ParkerVision Petition for Review
Mar 28, 2016 20:01 pm UTC| Business
JACKSONVILLE, Fla., March 28, 2016 -- ParkerVision, Inc. (NASDAQ:PRKR) (the “Company”) announced today that the Supreme Court of the United States has declined ParkerVision’s petition for a Writ of Certiorari requesting...
Mar 28, 2016 20:01 pm UTC| Business
CORALVILLE, Iowa, March 28, 2016 -- KemPharm, Inc. (NASDAQ:KMPH) announced today that its Investigational New Drug (IND) application for KP511, KemPharm’s prodrug of hydromorphone, has been accepted by the U.S. Food and...
CymaBay Announces the Appointment of Paul F. Truex and Robert J. Weiland to its Board of Directors
Mar 28, 2016 20:01 pm UTC| Business
NEWARK, Calif., March 28, 2016 -- CymaBay Therapeutics, Inc. (NASDAQ:CBAY), today announced the appointment of Paul F. Truex and Robert J. Weiland to the company’s Board of Directors, effective April 1, 2016. "I would...